Cevimeline hydrochloride hemihydrate
目录号: A15042
M1 激动剂
盐酸西维拉明半水合物是一种新型毒蕈碱受体激动剂,是治疗Sjogren综合症中干燥综合症(xerostomia)的候选药物。
Discription | Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. |
---|
目录号 | A15042 |
---|---|
分子式 | C20H38Cl2N2O3S2 |
分子量 | 489.6 |
CAS号 | 153504-70-2 |
SMILES | CC1O[C@]2(CN3CCC2CC3)CS1.CC1O[C@]2(CN3CCC2CC3)CS1.O.Cl.Cl |
其他名称 | Evoxac |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 35 mg/mL (142.98 mM) | |
Water | 35 mg/mL (142.98 mM) | ||
Ethanol | 35 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.42 mL | 102.12 mL | 204.25 mL |
0.5 mM | 4.08 mL | 20.42 mL | 40.85 mL |
1 mM | 2.04 mL | 10.21 mL | 20.42 mL |
5 mM | 0.41 mL | 2.04 mL | 4.08 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2